Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2011

01-06-2011 | SSIEM Symposium 2010

The use of continuous glucose monitoring in the practical management of glycogen storage disorders

Authors: Fiona J. White, Simon A. Jones

Published in: Journal of Inherited Metabolic Disease | Issue 3/2011

Login to get access

Abstract

Continuous glucose monitoring systems (CGMS) are now in widespread use in diabetes management with an increasing evidence base. There are few reports of their use in GSD. Liver glycogen storage disorders (GSDs) are most often managed by intensive dietary regimens. Risks of over and under-treatment remain. We describe our use of CGMS in a cohort of GSD patients, the results obtained and the frequency of complications. Our experience is that CGM is a reliable, well accepted and valid tool in the monitoring of GSD patients and allows for assessment of blood sugar control in the ‘real-life’ setting, unlike hospital admissions. Combining CGM with urine ketone and / or blood lactate measurements, again at home, improves the investigation yet further. It is possible to perform CGM for periods including both schooldays and weekends, and also to change the dietary regimen during the period of monitoring to reduce the frequency of assessments. Risks of decreased reliability in the low range of blood sugars may be outweighed by the increased validity of the patient being in the home environment, with a normal diet and activity schedule.
Literature
go back to reference Bergenstal RM, Tamborlane WV, Ahmann A et al. (2010) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 363(4):311–320PubMedCrossRef Bergenstal RM, Tamborlane WV, Ahmann A et al. (2010) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 363(4):311–320PubMedCrossRef
go back to reference De Block C, Manuel-y-Keenoy B, Van Gaal L (2008) A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol 2(4):718–727 De Block C, Manuel-y-Keenoy B, Van Gaal L (2008) A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol 2(4):718–727
go back to reference Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M (2001) Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 24(8):863–869PubMedCrossRef Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M (2001) Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 24(8):863–869PubMedCrossRef
go back to reference Maran A, Crepaldi C, Avogaro A et al. (2004) Continuous glucose monitoring in conditions other than diabetes. Diabetes Metab Res Rev 20(S2):S50–S55PubMedCrossRef Maran A, Crepaldi C, Avogaro A et al. (2004) Continuous glucose monitoring in conditions other than diabetes. Diabetes Metab Res Rev 20(S2):S50–S55PubMedCrossRef
go back to reference Medtronic (2009) Six day sensor trial, data on file. *MMT-7002/7003 Medtronic (2009) Six day sensor trial, data on file. *MMT-7002/7003
go back to reference Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP (2002) Guidelines for management of glycogen storage disease type I – European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S112–S119PubMedCrossRef Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP (2002) Guidelines for management of glycogen storage disease type I – European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S112–S119PubMedCrossRef
go back to reference Saunders AC, Feldman HA, Correia CE, Weinstein DA (2005) Clinical evaluation of a portable lactate meter in type I glycogen storage disease. J Inherit Metab Dis 28:695–701PubMedCrossRef Saunders AC, Feldman HA, Correia CE, Weinstein DA (2005) Clinical evaluation of a portable lactate meter in type I glycogen storage disease. J Inherit Metab Dis 28:695–701PubMedCrossRef
go back to reference Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K et al. (2002) Consensus guidelines for management of glycogen storage disease type 1b – European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 161(Suppl 1):S120–S123PubMed Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K et al. (2002) Consensus guidelines for management of glycogen storage disease type 1b – European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 161(Suppl 1):S120–S123PubMed
Metadata
Title
The use of continuous glucose monitoring in the practical management of glycogen storage disorders
Authors
Fiona J. White
Simon A. Jones
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9335-3

Other articles of this Issue 3/2011

Journal of Inherited Metabolic Disease 3/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.